Authors:
LEFEVRE G
DUVAL M
GAURON S
BROOKMAN LJ
ROLAN PE
MORRIS TM
PIRAINO AJ
MORGAN JM
PALMISANO M
CLOSE P
Citation: G. Lefevre et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 50-59
Authors:
MORGAN J
PALMISANO M
WALLACE D
SHELIGA A
HIRSCHHORN W
PIRAINO A
CAPUZZI D
Citation: J. Morgan et al., DETERGENT-INDUCED LIVER TRANSAMINASE ELEVATIONS IN A WELL-CONTROLLED EARLY PHASE-I DRUG TRIAL, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 10-10
Authors:
MORGAN JM
PALMISANO M
PIRAINO A
HIRSCHHORN W
SPENCER S
PRASAD PP
ORTIZ M
LLOYD P
Citation: Jm. Morgan et al., THE EFFECT OF VALSARTAN ON THE ANGIOTENSIN-II PRESSOR-RESPONSE IN HEALTHY NORMOTENSIVE MALE-SUBJECTS, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 35-44
Authors:
MORGAN JM
MCNULTY P
PALMISANO M
PIRAINO AJ
Citation: Jm. Morgan et al., THE EDUCATIONAL USE OF COMPUTER-SIMULATED PHARMACOKINETIC CURVES, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 97-97
Authors:
MORGAN J
STEVENS R
UZIELFUSI S
LAU H
HIRSCHHORN WL
MARSHALL P
PALMISANO M
PIRAINO A
Citation: J. Morgan et al., MULTIPLE-DOSE PHARMACOKINETICS OF A MONO-ARYL-AMIDINE COMPOUND (CGS-25019C) AND ITS INHIBITION OF DIHYDROXY-LEUKOTRIENES (LTB(4)) INDUCED CD11-BETA EXPRESSION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 153-153